An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.
On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.
An amendment numbered 2 printed in Part A of House Report 119-130 to require the Office of the National Coordinator to convene a public roundtable to examine how the expanded use of electronic health records among mental health and substance use service providers can improve outcomes for patients in mental health and substance use disorder settings and how best to increase Electronic Health Record adoption among such providers.
On agreeing to the Kiggans (VA) amendment (A002) Agreed to by voice vote.
An amendment numbered 3 printed in Part A of House Report 119-130 to codify Biden-era guidance to ensure that budget neutrality requirements for Section 1115 Waivers take into account downstream savings.
On agreeing to the Pettersen amendment (A003) Failed by recorded vote: 213 - 213 (Roll no. 150).
An amendment numbered 4 printed in Part A of House Report 119-130 to require HHS to convene a public meeting to improve awareness of, access to, and information related to funding opportunities related to mental health and SUD programs of SAMHSA grant programs.
On agreeing to the Wittman amendment (A004) Agreed to by voice vote.
This law extends funding through 2030 for a wide range of federal efforts to prevent and treat drug addiction and overdoses — things like helping states track prescription drug misuse, supplying police and first responders with overdose-reversal drugs like naloxone, funding addiction treatment and housing for people in recovery, and supporting pregnant women and children affected by substance use or trauma. It also adds some new pieces, like protecting the 988 mental health crisis phone line from hacking, requiring the government to publish guidance on safely disposing of unused medications at home, and studying whether a common addiction treatment drug (buprenorphine-naloxone) should be easier to prescribe. Separately, it makes it easier for pharmacies to mail certain closely monitored prescription drugs directly to doctors' offices instead of patients, and it broadens who can provide the training doctors need to get licensed to prescribe controlled substances. In short, patients seeking addiction treatment, people in recovery, pregnant women, children, first responders, healthcare providers, and states running these programs would all see continued or expanded federal support and slightly changed rules.
Not a claim about this bill's effect on this district — just the district's own real numbers, shown alongside the bill's real content.